// App-Quantinova.ai

PB1644 : THE NATURAL HISTORY OF SYSTEMIC AL AMYLOIDOSIS FOLLOWING UPFRONT TREATMENT WITH BORTEZOMIB: AN ANALYSIS OF REAL-WORLD LONGITUDINAL DATA

Researchers

Presenter

  • Sriram Ravichandran

Principal Investigators

  • Oliver Cohen

  • Steven Law

  • Darren Foard

  • Marianna Fontana

  • Ana Martinez-Nahharo

  • Carol Whelan

  • Julian Gillmore

  • Helen Lachmann

  • Sajitha Sachchithanantham

  • Shameem Mahmood

  • Philip Hawkins

  • Ashutosh Wechalekar

Medical Centers

  • National Amyloidosis Centre, University College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • AL Amyloidosis

Biomarkers

  • N/A

Drug/Treatment

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved